Publication | Open Access

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders

Hematological MalignancyThrombosisGenetic DisorderJak2 V617f MutationHematologyGenetic EpidemiologyPathologyNeurologyMedicineCerebral Venous ThrombosisMyeloid Neoplasia